Cargando…

Molecular chess? Hallmarks of anti-cancer drug resistance

BACKGROUND: The development of resistance is a problem shared by both classical chemotherapy and targeted therapy. Patients may respond well at first, but relapse is inevitable for many cancer patients, despite many improvements in drugs and their use over the last 40 years. REVIEW: Resistance to an...

Descripción completa

Detalles Bibliográficos
Autores principales: Cree, Ian A., Charlton, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214767/
https://www.ncbi.nlm.nih.gov/pubmed/28056859
http://dx.doi.org/10.1186/s12885-016-2999-1